Director/PDMR Shareholding

Genus plc (LSE: GNS) announces that further to the vesting on 2 May 2025 of nil-cost options granted on 2 May 2023 over ordinary shares, as listed in table A below, Jorgen Kokke, Chief Executive Officer, exercised 7,649 nil-cost options, sold 3,450 ordinary shares in Genus on 25 September 2025 on the London Stock Exchange to offset income tax and social security liabilities due on the exercise of those vested options and retained the balance of 4,199 ordinary shares.

The below notifications, made in accordance with Article 19 of the Market Abuse Regulation (EU) 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, give further detail on the number of nil-cost options exercised and ordinary shares sold on 25 September 2025.

• Name Genus plc
• LEI 54930022EOITNKSIGH56
• Description of the Financial instrument, type of instrument Identification code Ordinary shares of 10p each GB0002074580
• Nature of the transaction Exercise of nil-cost options granted on 2 May 2023 over ordinary shares in Genus.
• Price(s) and volume(s) Price Volume 0p 7,649
• Aggregated information · Aggregated volume · Price Price(s) Volume(s) 0p 7,649
• Place of the transaction Outside a trading venue.
• Description of the Financial instrument, type of instrument Identification code Ordinary shares of 10p each GB0002074580
• Nature of the transaction Sale of shares arising from the exercise of nil-cost options to offset income tax and social security liabilities due on the exercise.
• Price(s) and volume(s) Price Volume 2,331.99p 3,450
• Aggregated information · Aggregated volume · Price Price Volume 2,331.99p 3,450
• Place of the transaction London Stock Exchange, Main Market (XLON)